BMY Bristol-Myers Squibb Company
$60.57
Bristol-Myers Squibb Company (BMY) is confirmed to report earnings on October 29, 2026, before the market open. The consensus earnings estimate is $1.28 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -3.4% since its last earnings release on July 30, 2026.
Bristol-Myers Squibb Beat Expectations, Raises Guidance
Thursday, July 30, 2026 · 6:59 AM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 29
Thursday · 7:00 AM ET
Earnings Whisper
-
vs $1.28
Rev est $12.55B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$63.26
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Bristol-Myers Squibb Company
Bristol-Myers Squibb Co is a biopharmaceutical company. It discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products.
Sector
Healthcare
Industry
Drug Manufacturers / Major
Held By 12 ETFs, by dollar flow
- OEF iShares S&P 100 ETF
- XT iShares Exponential Technologies ETF
- XLG Invesco S&P 500 Top 50 ETF
- IOO iShares Global 100 ETF
- MOAT VanEck Morningstar Wide Moat ETF
- XLV Health Care Select Sector SPDR Fund
- IYH iShares U.S. Healthcare ETF
- IXJ iShares Global Healthcare ETF
- BMED iShares Health Innovation Active ETF
- PPH VanEck Pharmaceutical ETF
- XPH SPDR S&P Pharmaceuticals ETF
- IHE iShares U.S. Pharmaceuticals ETF
Charts powered in part by Lightweight Charts™ by TradingView.